Cambridge-based FoldRx Pharmaceuticals Raises $29M, and yes, they are hiring!
0 followers
0 Likes
From New England Tech Wire | June 15, 2010
Cambridge, Mass. -- FoldRx Pharmaceuticals, a privately held, Cambridge-based firm, announced on Tuesday that it has raised $29 million financing in a venture capital deal, led by Novo Ventures and Morgenthaler Ventures. Founded in 2003, FoldRx is focused on developing small molecule therapeutics to treat diseases of protein misfolding and aggregation. The company is building a pipeline, initially for neurodegenerative and cardiovascular conditions. Other investors in FoldRx include Healthcare Ventures, Fidelity Biosciences, TPG Biotechnology, Alta Partners, and Novartis Venture Funds.
0 Replies
Reply
Subgroup Membership is required to post Replies
Join Better Jobs Faster now
Suggested Posts
| Topic | Replies | Likes | Views | Participants | Last Reply |
|---|---|---|---|---|---|
| Be Self-Employed Writing Content | 0 | 0 | 292 | ||
| Work from Home Writing Articles | 0 | 0 | 120 | ||
| Band Together Seeks New Executive Director in Raleigh Area | 0 | 0 | 525 |